Get the Stockscreener App
17.18
1.26%
-0.22
After Hours:
17.84
0.66
+3.84%
Travere Therapeutics Inc Stock (TVTX) Forecast
The Travere Therapeutics Inc (TVTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $16.70, representing a -2.82% decrease from the current price of $17.18. The highest analyst price target is $19.45, and the lowest is $13.94.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TVTX Price Target
Average 16.88
(-1.76% Downside)
Is Travere Therapeutics Inc (TVTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.16 | Neutral |
| STOCH(9,6) | 11.60 | Buy |
| STOCHRSI(14) | 19.10 | Buy |
| MACD(12,26) | -0.2191 | Sell |
| ADX(14) | 26.58 | Sell |
| William %R | -84.26 | Buy |
| CCI(14) | -68.89 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
17.75
Sell
|
17.66
Sell
|
| MA20 |
18.37
Sell
|
17.97
Sell
|
| MA50 |
18.12
Sell
|
17.38
Sell
|
| MA100 |
14.87
Buy
|
15.45
Buy
|
| MA200 |
11.18
Buy
|
13.12
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, TVTX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on TVTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.16 indicates that TVTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.6 indicates that TVTX is oversold. This indicates that TVTX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.1 indicates that TVTX is oversold. This suggests that TVTX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.58 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -68.89 indicates that TVTX is still oversold but not to an extreme extent.
Long-term TVTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Travere Therapeutics Inc financial reports and earnings history, Travere Therapeutics Inc (TVTX) stock could reach $2.934 by 2030, $41.16 by 2040 and $48.58 by 2050. See the projected annual prices until 2050 of the Travere Therapeutics Inc stock below:
- Travere Therapeutics Inc (TVTX) is expected to reach an average price of $3.5735 in 2035, with a high prediction of $2.3635 and a low estimate of $2.2974. This indicates an $-79.20% rise from the last recorded price of $17.18.
- Travere Therapeutics Inc (TVTX) stock is projected to chart a bullish course in 2040, with an average price target of $41.25, representing an $140.10% surge from its current level. The forecast ranges from a conservative $12.99 to a sky-high $41.16.
- Our analysts predict Travere Therapeutics Inc (TVTX) to jump 24.21% by 2045, soaring from $21.96 to an average price of $21.34, potentially reaching $20.99. While $21.96 is the low estimate, the potential upside is significant.
- Travere Therapeutics Inc (TVTX) stock is expected to climb by 2050, reaching an average of $47.56, a $176.86% jump from its current level. However, a wide range of estimates exists, with high and low targets of $48.58 and $48.58, respectively, highlighting the market's uncertainty.
Travere Therapeutics Inc Stock (TVTX) Year by Year Forecast
Travere Therapeutics Inc Stock (TVTX) Price Forecast for 2025
Travere Therapeutics Inc Stock (TVTX) is expected to reach an average price of $16.88 in 2025, with a high prediction of $22.38 and a low estimate of $11.37. This indicates an -1.76% fall from the last recorded price of $17.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $17.66 | $13.94 | $19.45 | +2.79% |
| February, 2025 | $19.69 | $17.51 | $22.38 | +14.61% |
| March, 2025 | $16.35 | $12.94 | $20.60 | -4.82% |
| April, 2025 | $17.13 | $13.66 | $17.56 | -0.31% |
| May, 2025 | $17.65 | $15.56 | $19.22 | +2.73% |
| June, 2025 | $20.46 | $14.63 | $20.55 | +19.09% |
| July, 2025 | $20.04 | $18.51 | $21.80 | +16.62% |
| August, 2025 | $17.59 | $15.92 | $20.98 | +2.37% |
| September, 2025 | $16.03 | $13.52 | $19.53 | -6.71% |
| October, 2025 | $12.75 | $12.18 | $16.01 | -25.76% |
| November, 2025 | $13.09 | $11.37 | $14.08 | -23.78% |
| December, 2025 | $14.93 | $12.28 | $15.47 | -13.09% |
Travere Therapeutics Inc Stock (TVTX) Price Forecast for 2026
The predicted value for Travere Therapeutics Inc (TVTX) in 2026 is set at an average of $8.8685. Estimates vary from a peak of $17.21 to a trough of $0.5228, indicating an -48.38% surge from the present price of $17.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.21 | $14.07 | $16.56 | -17.28% |
| February, 2026 | $16.51 | $11.58 | $16.94 | -3.88% |
| March, 2026 | $16.49 | $13.55 | $17.08 | -3.99% |
| April, 2026 | $10.98 | $8.6902 | $17.21 | -36.09% |
| May, 2026 | $12.21 | $9.8907 | $12.49 | -28.92% |
| June, 2026 | $10.60 | $10.42 | $13.93 | -38.29% |
| July, 2026 | $11.89 | $9.5431 | $12.10 | -30.80% |
| August, 2026 | $8.3493 | $8.3393 | $12.24 | -51.40% |
| September, 2026 | $8.6456 | $7.3896 | $10.28 | -49.68% |
| October, 2026 | $2.1965 | $1.7515 | $8.9608 | -87.21% |
| November, 2026 | $2.2075 | $1.5875 | $2.6218 | -87.15% |
| December, 2026 | $1.8337 | $0.5228 | $2.5028 | -89.33% |
Travere Therapeutics Inc Stock (TVTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Travere Therapeutics Inc (TVTX) is $7.7211, with a high forecast of $14.37 and a low forecast of $1.071. This indicates an -55.06% decrease from the last price of $17.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.5447 | $1.459 | $5.2546 | -73.55% |
| February, 2027 | $4.2957 | $3.9991 | $5.8952 | -75.00% |
| March, 2027 | $3.8119 | $3.5269 | $5.0509 | -77.81% |
| April, 2027 | $3.5029 | $3.4372 | $5.0077 | -79.61% |
| May, 2027 | $2.5239 | $2.4039 | $4.4581 | -85.31% |
| June, 2027 | $3.45 | $1.3444 | $3.36 | -79.92% |
| July, 2027 | $2.512 | $1.071 | $3.682 | -85.38% |
| August, 2027 | $5.9239 | $3.2324 | $7.3734 | -65.52% |
| September, 2027 | $10.85 | $5.4644 | $10.92 | -36.87% |
| October, 2027 | $11.33 | $10.54 | $13.44 | -34.06% |
| November, 2027 | $12.34 | $7.5103 | $12.92 | -28.17% |
| December, 2027 | $8.5027 | $7.9922 | $14.37 | -50.51% |
Travere Therapeutics Inc Stock (TVTX) Price Forecast for 2028
In 2028, Travere Therapeutics Inc (TVTX) is projected to reach an average price of $9.7707, with a high projection of $14.47 and a low estimate of $5.072. This indicates an -43.13% fall from the last price of $17.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $11.18 | $6.7132 | $12.11 | -34.90% |
| February, 2028 | $9.8066 | $8.2256 | $12.32 | -42.92% |
| March, 2028 | $11.69 | $5.7271 | $11.83 | -31.96% |
| April, 2028 | $9.261 | $9.011 | $14.41 | -46.09% |
| May, 2028 | $7.7935 | $5.072 | $10.70 | -54.64% |
| June, 2028 | $8.9554 | $6.0049 | $11.61 | -47.87% |
| July, 2028 | $9.5574 | $7.9759 | $10.78 | -44.37% |
| August, 2028 | $11.92 | $7.2589 | $14.47 | -30.62% |
| September, 2028 | $13.01 | $11.24 | $13.99 | -24.26% |
| October, 2028 | $10.66 | $8.8683 | $13.86 | -37.93% |
| November, 2028 | $7.0762 | $6.5342 | $10.62 | -58.81% |
| December, 2028 | $6.7281 | $5.2981 | $8.9172 | -60.84% |
Travere Therapeutics Inc Stock (TVTX) Price Forecast for 2029
The 2029 price forecast for Travere Therapeutics Inc Stock (TVTX) is $6.7288 on average, with a high prediction of $11.25 and a low estimate of $2.2042. This represents an -60.83% decrease from the previous price of $17.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.9806 | $4.7787 | $8.3906 | -53.55% |
| February, 2029 | $9.1125 | $6.4016 | $9.3725 | -46.96% |
| March, 2029 | $5.3345 | $5.3345 | $10.69 | -68.95% |
| April, 2029 | $8.5265 | $6.285 | $10.60 | -50.37% |
| May, 2029 | $8.4689 | $7.5174 | $11.25 | -50.70% |
| June, 2029 | $4.2209 | $2.8704 | $11.11 | -75.43% |
| July, 2029 | $7.7628 | $4.1413 | $7.7978 | -54.81% |
| August, 2029 | $4.5853 | $4.1053 | $8.3257 | -73.31% |
| September, 2029 | $6.5372 | $4.1462 | $6.9171 | -61.95% |
| October, 2029 | $3.9797 | $2.2042 | $6.6477 | -76.84% |
| November, 2029 | $2.1684 | $3.0184 | $5.1601 | -87.38% |
| December, 2029 | $2.5064 | $2.4024 | $2.2464 | -85.41% |
Travere Therapeutics Inc Stock (TVTX) Price Forecast for 2030
Travere Therapeutics Inc Stock (TVTX) is expected to reach an average price of $6.4391 in 2030, with a high forecast of $12.81 and a low forecast of $0.0681. This signifies an -62.52% decrease from the last price of $17.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.534 | $2.9659 | $2.934 | -79.43% |
| February, 2030 | $0.462 | $3.092 | $3.2735 | -97.31% |
| March, 2030 | $0.1801 | $0.0694 | $1.0099 | -98.95% |
| April, 2030 | $0.3919 | $0.0681 | $1.5204 | -97.72% |
| May, 2030 | $0.6257 | $0.2971 | $0.6633 | -96.36% |
| June, 2030 | $0.0237 | $0.4597 | $0.9853 | -99.86% |
| July, 2030 | $2.2913 | $0.7232 | $1.5913 | -86.66% |
| August, 2030 | $8.0543 | $1.8703 | $12.81 | -53.12% |
| September, 2030 | $4.2713 | $6.0413 | $6.3585 | -75.14% |
| October, 2030 | $1.0127 | $2.8127 | $2.4056 | -94.11% |
| November, 2030 | $3.2303 | $1.4854 | $4.4803 | -81.20% |
| December, 2030 | $2.1032 | $1.4432 | $4.2575 | -87.76% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):